Skip to main content
Robert Rushakoff, MD, Endocrinology, San Francisco, CA

Robert J. Rushakoff MD

Diabetes, Lipid Metabolism


Professor of Medicine, UCSF

Join to View Full Profile
  • 1600 Divisadero StSan Francisco, CA 94143

  • Phone+1 415-885-3868

  • Fax+1 415-884-7724

Dr. Rushakoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1987
  • University of California (San Francisco)/Mount Zion
    University of California (San Francisco)/Mount ZionResidency, Internal Medicine, 1982 - 1985
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1984 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Collateral Damage: Insulin-Dependent Diabetes Induced with Checkpoint Inhibitors  
    Robert Rushakoff, Zoe Quandt, James Lee, Kevan C Herold, Diabetes Care

Lectures

  • The Virtual Inpatient Glucose Management Service: Improving Glucose Control and Decreasing Therapeutic Inertia 
    San Francisco, CA - 6/15/2014

Press Mentions

  • Dilemmas in Diabetes
    Dilemmas in DiabetesDecember 9th, 2019
  • Many People with Diabetes Can't Afford 'Good' Insulin. What Should They Know About Switching to the Cheaper Stuff?
    Many People with Diabetes Can't Afford 'Good' Insulin. What Should They Know About Switching to the Cheaper Stuff?August 20th, 2019
  • Diabetes After 50 Could Be Early Sign of Pancreatic Cancer, Study Says
    Diabetes After 50 Could Be Early Sign of Pancreatic Cancer, Study SaysJune 19th, 2018
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: